| Amiodarone |
Mechanism of Action
Antidysrythmic agent with multiple mechanisms of action
Indications
Persistent V-fib/Pulseless V-Tach. Stable uncontrolled wide-complex tachycardias
Packaging
150 mg in 3 ml (ampule)
Drug box inventory = 3
Onset & Duration
Onset: 1-5 min
Duration: less than 2 hours
Doses and Administration
V-Fib/Pulseless V-Tach – 1st Dose - 300 mg IV
Bolus 2nd Dose – 150 mg IV Bolus
Stable Wide Complex Tachycardia – 150 mg drip over 10 min
Contraindications
Pulmonary Congestion
Cardiogenic Shock
Hypotension
Hypersensitivity
Hypotension
Precautions
Continuous ECG monitoring is required
Side Effects are possible
Hypotension
Headache
Dizziness
Bradycardia
AV Conduction Abnormalities
Pediatrics
V-Fib/Pulseless V-Tach - 1st Dose - 5 mg/kg IV/IO
2nd Dose – 2.5 mg/kg IV/IO
Max dose 15 mg/kg
Antidysrythmic agent with multiple mechanisms of action
Indications
Persistent V-fib/Pulseless V-Tach. Stable uncontrolled wide-complex tachycardias
Packaging
150 mg in 3 ml (ampule)
Drug box inventory = 3
Onset & Duration
Onset: 1-5 min
Duration: less than 2 hours
Doses and Administration
V-Fib/Pulseless V-Tach – 1st Dose - 300 mg IV
Bolus 2nd Dose – 150 mg IV Bolus
Stable Wide Complex Tachycardia – 150 mg drip over 10 min
Contraindications
Pulmonary Congestion
Cardiogenic Shock
Hypotension
Hypersensitivity
Hypotension
Precautions
Continuous ECG monitoring is required
Side Effects are possible
Hypotension
Headache
Dizziness
Bradycardia
AV Conduction Abnormalities
Pediatrics
V-Fib/Pulseless V-Tach - 1st Dose - 5 mg/kg IV/IO
2nd Dose – 2.5 mg/kg IV/IO
Max dose 15 mg/kg
